Swiss EE Study Group: Clinical Trials

2 trials sponsored by Swiss EE Study Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Swiss EE Study Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
Infliximab - Esophagitis
Phase 2CompletedSwiss EE Study Group2007-08-012009-04-07
Budesonide for Eosinophilic Esophagitis
Budesonide - Eosinophilic Esophagitis
Phase 2CompletedSwiss EE Study Group282005-12-012015-05-22

Conditions studied

Eosinophilic Esophagitis (2)  ·  Esophagitis (1)

Interventions

Budesonide (1)  ·  Infliximab (1)

Countries

Switzerland (2)

Top investigators

Alex Straumann, MD (1)  ·  Christoph Beglinger, MD (1)  ·  Hans-Uwe Simon, MD and PhD (1)  ·  Hans-Uwe Simon, MD, PhD (1)